Multiple myeloma is the second most common hematologic malignancy in adults and represents 10% to 20% of all hematologic cancers. It is a malignancy of plasma cells that accumulate in the bone marrow, usually, secrete large amounts of paraprotein, and cause the destruction of the bones. However, the presenting symptoms of multiple myeloma are vague and nonspecific.
Therefore, early detection poses a diagnostic challenge in primary care. In this video, Dr. Jagdev Singh Sekhon discusses Multiple myeloma - definition, epidemiology, clinical symptoms, what are the early detection challenges and consequences of delay in diagnosis .
